Top Markets
Coin of the day
Bright Minds Biosciences Inc. Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc.

DRUG
Hisse Senetlerindeki Sıralama #11319
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Hisse Fiyatı
$73.12
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$715.61M
Değişim (1 gün)
-1.90%
Değişim (1 yıl)
88.01%
Ülke
US
Ticaret Bright Minds Biosciences Inc. (DRUG)

Kategori

Bright Minds Biosciences Inc. (DRUG) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $78.82 - 2026-08-01

Gün sonu en düşük fiyat: $26.78 - 2021-03-01
Bright Minds Biosciences Inc. için hisse fiyatı geçmişi: 2021 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -9.92%
2025 104.69%
2024 2,591.40%
2023 -68.68%
2022 -73.75%
2021 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH